drugset / Trial / NCT03895411

Efficacy and Safety of Sotalol in Children With Arrhythmia

NCT03895411

Phase 4 Unknown 500 enrolled Shengjing Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to investigate the efficacy and safety of oral sotalol alone or combination with other anti-arrhythmic medicines in the treatment of arrhythmias in children. The study will regularly monitor the Holter, electrocardiogram (ECG), Echocardiography (Echo), blood routine, urine routine, serum ion, liver and kidney function, troponin I, hypersensitive troponin T, N-terminal pro-brain natriuretic peptide (NT pro-BNP), etc, before and after receive sotalol therapy. Compare the degree of arrhythmia improvement in patients and the side effects after oral sotalol.

Timeline

Start
2019-08
Primary completion
2020-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator propafenone Unknown 5 mg/kg Oral
Subject sotalol Small molecule 2.5 mg/kg Oral
Background Metoprolol Other / unclassified 0.5 mg/kg Oral